Physician profile
Robert Comer
NPI 1205056041
$2,386.21
in general payments reported to CMS, 2019-2025
16 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $463 · 2020: $345 · 2021: $141 · 2022: $341 · 2023: $492 · 2024: $379 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,097.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $624.57 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $545.64 | 2019-2025 | Veklury |
| Insmed, INC. | $339.78 | 2019-2025 | Arikayce |
| Abbvie INC. | $214.29 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $163.18 | 2019-2025 | Zerbaxa, Dificid, Recarbrio |
| Janssen Biotech, INC. | $109.20 | 2019-2021 | |
| Melinta Therapeutics, LLC | $81.11 | 2023-2025 | Rezzayo, Kimyrsa, Orbactiv |
| La Jolla Pharmaceutical Company | $63.79 | 2023-2024 | Xerava, Xacduro |
| Astellas Pharma US INC | $61.19 | 2019-2020 | |
| Shionogi INC | $34.15 | 2021-2022 | |
| Mylan Institutional INC. | $33.60 | 2019 | |
| Paratek Pharmaceuticals, INC. | $32.05 | 2022-2024 | Nuzyra |
| Theratechnologies INC. | $29.23 | 2022 | |
| Boston Scientific Corporation | $20.72 | 2019 | |
| Dynavax Technologies Corporation | $17.40 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Electromed, INC. | $16.31 | 2023 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Comer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.